The Initial Response of Blood Leukocytes to Incubation with Perfluorocarbon Blood Substitute Emulsions

References

• Virmani R., Fink L. M., Gunter K., English D. Effect of perfluorochemical blood substitutes on human neutrophil function. Transfusion 1984; 24: 343–347
   PubMedGoogle Scholar
• Lane T. A., Lamkin G. E. Paralysis of phagocyte migration due to an artificial blood substitute. Blood 1984; 2: 400–405
   Google Scholar
• Forman M. B., Pitarys C. J., II, Vildibill H. D., Lambert T. L., Ingram D. A., Virmani R., Murray J. J. Pharmacologic perturbation of neutrophils by fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. JACC 1992; 19: 205–216
   Google Scholar
• Ingram D. A., Forman M. B., Murray J. J. Phagocytic activation of human neutrophils by the detergent component of fluosol. American Journal of Pathology 1992; 140: 1081–1087
   PubMed Web of Science ®Google Scholar
• Forman M. B., Ingram D. A., Murray J. J. Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury. American Heart Journal 1992; 124: 1347–1357
   PubMedGoogle Scholar
• Forman M. B., Puett D. W., Wilson B. H., Vaughn W. K., Friesinger G. C., Virmani R. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model. J Am Coll Cardiol 1987; 9: 1082–1090
   PubMed Web of Science ®Google Scholar
• McDonagh P. F., Reynolds J. M. Brief perfusion with diluted whole blood after global myocardial ischaemia increases reperfusion injury. Cardiovascular Research 1994; 28, In Press
   PubMedGoogle Scholar
• McDonagh P. F., Rauzzino M. J. Stimulated leukocyte adhesion in the coronary microcirculation is reduced by a calcium antagonist. American Journal of Physiology 1993; 265: H476–H483
   Google Scholar
• Cleman M., Jaffe C. C., Wohlgelernter D. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol®-DA20%. Circulation 1986; 74: 555–562
   PubMed Web of Science ®Google Scholar
• Kent K. M., Cleman M. W., Cowley M. J., Forman M. B., Jaffe C., Kaplan M., King J. B., Krucoff M. W., Lasser T., McAuley B., Smith R., Wisdom C., Wohlgelernter D. Reduction of myocardial ischemia during percutaneous coronary angioplasty with oxygenated Fluosol®. Am J Cardiol 1990; 66: 279–284
   PubMed Web of Science ®Google Scholar
• Ogilby J. D., Noma S., DiLoretto G., Stets G. Preservation of myocardial function during ischemia with intracoronary perfluoroocytlbromide. Biomat art cells and immob biotech 1992; 20: 973–977
   PubMed Web of Science ®Google Scholar
• Engelman R. M., Rousou J. H., Dobbs W. A. Fluosol-DA: An artificial blood for total cardiopulmonary bypass. Ann Thorac Surg 1981; 32: 528–535
   PubMed Web of Science ®Google Scholar
• Kanter K. R., Jaffrn J. H., Ehrlichman R. J., Flaherty J. T., Gott V. L., Gardner T. J. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia. Circulation 1991; 64(Suppl 2)75–80
   Google Scholar
• Gartman D. M., McDonagh P. F., Geha A. S. Cold protected hearts extract oxygen from Flousol-DA during cardiopulmonary bypass. Oxygen transport to tissue VI, D. Bruley, H. I. Bicher, D. Reneau, 1985; 443–450
   Google Scholar
• Pearl J. M., Laks H., Drinkwater D. C., Meneshian A., Martin S. M., Curzan M., Chang P. A. Fluosol Cardioplegia results in complete functional recovery: a comparison with blood cardioplegia. Ann Thorac Surg 1992; 54: 1144–1150
   PubMedGoogle Scholar
• Forman M. B., Bingham S., Kopelman H. A., Wehr C., Sandler M. P., Kolodgie F., Vaughn W. K., Friesinger G. C., Virmani R. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1985; 71: 1060–1068
   PubMed Web of Science ®Google Scholar
• Reynolds J. M., McDonagh P. F. Early in reperfusion leukocytes alter perfused coronary capillarity and vascular resistance. American Journal of Physiology 1989; 256: H982–H989
   Google Scholar
• Bajaj A. K., Cohb M. A., Virmani R., Gay J. C., Light R. T., Forman M. B. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: Role of neutrophil activation. Circulation 1989; 79: 645–656
   PubMed Web of Science ®Google Scholar
• Babbitt D. G., Forman M. B., Jones R., Bajaj A. K., Hoover R. L. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical. American Journal of Pathology 1990; 136: 451–459
   PubMed Web of Science ®Google Scholar
• Martin S. M., Laks H., Drinkwater D. C., Stein D. G., Capouya E. R., Pearl J. M., Barthel S. W., Chang P., Kaczer E., Bhuta S. Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia. Ann. Thorac. Surg 1993; 55: 954–960
   PubMedGoogle Scholar